Day 1 // 26th February 2020


"The Social Acceptance of Medical Devices"

Prof. Dr. Bertolt Meyer
Professorship of Organizational- and Economic Psycholgy at the TU Chemnitz

Prof. Dr. Bertolt Meyer has been Professor of Organizational and Economic Psychology at Chemnitz University of Technology since 2014. He is also Dean of Studies of the Faculty of Humanities and Social Sciences. His research focuses on health at work and the social impact of digitization. For example, a recent study shows that bionic technology can even change our societal view of disability. Meyer and his research have received widespread media coverage, including in the award-winning documentary "Homo Digitalis" (arte / BR, 2017). Meyer is a part-time brand ambassador for the manufacturer of his bionic hand.

PANEL Cell and immune therapy

"A Cell Culture GMP Facility of the Future Implemented in the Present"

Dr. Andreas Eberle

Dr. Andreas Eberle serves as VP Head of Global Manufacturing, bringing with him broad experience in the pharmaceutical industry with regard to planning and implementation of pharmaceutical facilities, aseptic processing and leadership of commercial pharmaceutical facilities around the whole supply chain. With over 21 years of experience in the pharmaceutical industry, such as qualification, validation, engineering, process development, process optimization, and management of large production units, he ensures that Manufacturing department is the heart of CO.DON. Dr. Eberle previously worked for IDT Biologika GmbH, ratiopharm (Merckle GmbH), Johnson & Johnson, Aventis Behring and LSMW GmbH.

PANEL Chemistry and biosystems technology

PD Dr. Christian Growitsch
Director Center for Economics of Materials CEM and deputy director of the Fraunhofer Institute for Microstructure of materials and Systems IMWS

Christian Growitsch advises industry and politics on techno-economic issues concerning the transformation towards a sustainable industrial society. He is research fellow at the Energy Policy Research Group an der University of Cambridge, the Institute of Energy Economics at the University of Cologne (EWI) and visiting scholar at the University of Hamburg. Since 2017 Christian Growitsch has been teaching economics at the Martin-Luther-University Halle-Wittenberg.

PANEL 5 years BNAL (Bio-Nanotechnology Application Laboratory)

Dr. Jörg Opitz
Fraunhofer Institute for Ceramic Technologies and Systems IKTS

Jörg Opitz has been head of the "Bio- and Nanotechnology" department at Fraunhofer IKTS since 2015 and is the main contact person for the "Bio- and Medical Technology" business unit. He conducts research in the fields of biotechnology, cancer research, bioengineering, nanotechnology and optical monitoring. Current research activities focus on surface modification and functionalization for biological and medical applications as well as on the optical monitoring of additive manufacturing process technologies.


Prof. em. Dr. Hannelore Daniel

Hannelore Daniel held the position of a Chair of Physiology of Human Nutrition at the Technical University of Munich (TUM), Germany. Her main research interests are control mechanisms in mammalian metabolism; studied in model organisms and humans by using a diversity of cell and molecular techniques and metabolomics for more comprehensive and better phenotyping. Some of the research relates directly to approaches for personalised nutrition. Hannelore is a nutrition expert by training and worked in Germany, UK and USA. She is a member of the German National Academy of Sciences and an advisor for national and international funding agencies, research centers and the EU commission. Hannelore Daniel has published around 450 scientific papers and reviews and and received numerous scientific awards including the "Pro meritis-Award" and the Silver medal of the State of Bavaria.

Day 2 // 27th February 2020


Dr. Peter Mandry
B. Braun Avitum Saxonia GmbH

Dr. Peter Mandry works as Plant Manager and Head of Innovation at B. Braun Avitum Saxonia GmbH. In his career he was Managing Director, Head of Marketing, R&D and Production Departments in several companies of the Fresenius and B. Braun groups. He is inventor of many medical products. He received the German Innovation Price for Medical Engineering. Besides the development and marketing of therapies Mandry is committed to increase patient safety in hospitals. Besides classic and digital safety product approaches, Mandry campaigns with lectures, science slams and publications.

PANEL Imaging and evaluation

Dr. Andrei Tchernook
JENOPTIK Optical Systems GmbH

Dr. Andrei Tchernook is head of the R&D department Bioimaging Solutions at Jenoptik's SBU Biophotonics. Among other things, he is responsible for the development of the miniaturised digital imaging platform JENOPTIK SYIONS. With his many years of experience in micro- and nanoscopic imaging as well as in medical technology, he continues to work as a visionary, organizer and networker. One motivation is to close the technological gap between biological and biochemical objects and high-quality data for today's and future generations of intelligent analytical and medical devices.

PANEL e-health & digital health management

"How digital therapies will bring added value to patients, foster behavior change and increase medical adherence"

Jeremy Dähn
curalie GmbH

Jeremy Dähn is a Senior Manager at Curalie, the spin-off of Helios Hospital Group, Europe’s largest hospital provider and part of Fresenius. He is responsible for strategy, technology scouting and market analysis with a high level of insight, both in a clinical setting and in the startup ecosystem in Germany and Europe. As an in-house consultant for the Helios board, he developed a strategy for Curalie and Helios with a focus on digitization and ambulatory care. He heads collaboration and consulting projects within Fresenius as well with other hospital providers, pharmaceutical companies, and industry partners to evaluate new business opportunities. Jeremy is a business mentor of Startup Creasphere by Plug&Play, Grants4Apps by Bayer AG and is a member of the district management council in Neukölln (Berlin, Germany).

PANEL Diagnostics

"Next Gen Sequencing in diagnostics and health care"

Dr. Kerstin Stangier
GENEWIZ Germany GmbH/Brooks Life Science

Dr. Kerstin Stangier is Senior Director of GENEWIZ Germany GmbH. Before she started building the European headquarters of GENEWIZ in 2017, she worked for GATC Biotech for 15 years. In addition to her many years of experience in marketing and sales, she also has extensive expertise in the areas of production and laboratory management. Since 2012, Dr. Stangier has also been a member of the board of the national industry association IWBio.